Krishna S. Gunturu

1.5k total citations
29 papers, 558 citations indexed

About

Krishna S. Gunturu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Krishna S. Gunturu has authored 29 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Hepatology. Recurrent topics in Krishna S. Gunturu's work include Cancer Immunotherapy and Biomarkers (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Krishna S. Gunturu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Krishna S. Gunturu collaborates with scholars based in United States and Canada. Krishna S. Gunturu's co-authors include Howard S. Höchster, Jaykumar Thumar, Xiaopan Yao, Xiangyu Cong, Jill Lacy, Stacey Stein, Sarju Ganatra, Anju Nohria, Sourbha S. Dani and Helen Remotti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Krishna S. Gunturu

26 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krishna S. Gunturu United States 12 343 153 91 87 77 29 558
Maria Vadiaka Greece 13 423 1.2× 194 1.3× 44 0.5× 99 1.1× 140 1.8× 37 697
Angélique Da Silva France 7 451 1.3× 176 1.2× 30 0.3× 98 1.1× 51 0.7× 19 580
Demetris Papamichael Cyprus 16 674 2.0× 267 1.7× 85 0.9× 62 0.7× 122 1.6× 39 959
Mehmet Küçüköner Türkiye 14 230 0.7× 253 1.7× 80 0.9× 39 0.4× 116 1.5× 74 591
Michael Cecchini United States 12 297 0.9× 161 1.1× 111 1.2× 24 0.3× 151 2.0× 79 601
Yingyi Zhang China 10 114 0.3× 155 1.0× 45 0.5× 88 1.0× 117 1.5× 21 448
Tomohiro Sakamoto Japan 11 237 0.7× 257 1.7× 78 0.9× 75 0.9× 101 1.3× 47 461
Oktay Bozkurt Türkiye 13 248 0.7× 113 0.7× 105 1.2× 29 0.3× 88 1.1× 44 427
Anne‐Flore Plane France 6 479 1.4× 168 1.1× 20 0.2× 178 2.0× 63 0.8× 13 656
Xiaojuan Zhang China 11 259 0.8× 260 1.7× 83 0.9× 31 0.4× 144 1.9× 39 515

Countries citing papers authored by Krishna S. Gunturu

Since Specialization
Citations

This map shows the geographic impact of Krishna S. Gunturu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna S. Gunturu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna S. Gunturu more than expected).

Fields of papers citing papers by Krishna S. Gunturu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna S. Gunturu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna S. Gunturu. The network helps show where Krishna S. Gunturu may publish in the future.

Co-authorship network of co-authors of Krishna S. Gunturu

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna S. Gunturu. A scholar is included among the top collaborators of Krishna S. Gunturu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna S. Gunturu. Krishna S. Gunturu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunturu, Krishna S., Hollis Viray, Andrew J. Piper‐Vallillo, et al.. (2024). Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. Lung Cancer. 198. 108023–108023. 1 indexed citations
2.
Vaidya, Riha, Amy K. Darke, Krishna S. Gunturu, et al.. (2023). Examining uptake of electronic patient reported outcomes (ePRO) in a prospective study of immune-related adverse events (IR-AEs).. JCO Oncology Practice. 19(11_suppl). 368–368. 1 indexed citations
3.
Viray, Hollis, Katherine A. Stafford, Mary‐Elizabeth Patti, et al.. (2023). Obesity, dyslipidemia, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer.. Journal of Clinical Oncology. 41(16_suppl). e21125–e21125. 1 indexed citations
4.
Gunturu, Krishna S., et al.. (2022). Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients. Supportive Care in Cancer. 30(5). 4019–4026. 17 indexed citations
5.
Gil, B., et al.. (2022). Safety of sequential immune checkpoint inhibitors after prior immune therapy. Journal of Cancer Research and Clinical Oncology. 149(6). 2375–2382. 3 indexed citations
6.
Stafford, Katherine A., et al.. (2022). Obesity diabetes and dyslipidemia as determinants of immune checkpoint inhibitors response in non-small cell lung cancer.. Journal of Clinical Oncology. 40(16_suppl). e21104–e21104.
7.
Patel, Rushin, Rohan Parikh, Krishna S. Gunturu, et al.. (2021). Cardiotoxicity of Immune Checkpoint Inhibitors. Current Oncology Reports. 23(7). 79–79. 88 indexed citations
8.
Raibagkar, Pooja, Doreen Ho, Krishna S. Gunturu, & Jayashri Srinivasan. (2020). Worsening of Anti-Hu Paraneoplastic Neurological Syndrome related to Anti-PD-1 Treatment: Case Report and Literature Review (1230). Neurology. 94(15_supplement). 1 indexed citations
9.
10.
Gunturu, Krishna S., et al.. (2020). 284 Real World Data of Sequencing Immune Checkpoint Inhibitors (ICI) after Initial ICI. SHILAP Revista de lepidopterología. A174.1–A174.
11.
Ganatra, Sarju, Anju Nohria, Sachin Shah, et al.. (2019). Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series. Cardio-Oncology. 5(1). 1–1. 57 indexed citations
12.
Nugent, F. Warren, Amy E.B. Packard, K.U. Hunter, et al.. (2018). Economic analysis of transarterial chemoembolization (TACE) versus stereotactic body radiotherapy (SBRT) for the treatment of hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 36(4_suppl). 508–508. 4 indexed citations
13.
14.
Nugent, F. Warren, Krishna S. Gunturu, Keith Stuart, et al.. (2017). A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) as a bridge to transplant in hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 35(15_suppl). e15677–e15677. 4 indexed citations
15.
Gunturu, Krishna S., Maysa Abu‐Khalaf, & Muhammad Wasif Saif. (2015). Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient with Pancreatic Cancer. PubMed. 11(5). 484–5. 2 indexed citations
16.
Gunturu, Krishna S., Yanghee Woo, Nike Beaubier, Helen Remotti, & Muhammad Wasif Saif. (2013). Gastric cancer and trastuzumab: first biologic therapy in gastric cancer. Therapeutic Advances in Medical Oncology. 5(2). 143–151. 64 indexed citations
17.
Gunturu, Krishna S., Jaykumar Thumar, Howard S. Höchster, et al.. (2012). Single institution experience with FOLFIRINOX in advanced pancreatic cancer (PC).. Journal of Clinical Oncology. 30(15_suppl). e14534–e14534. 9 indexed citations
18.
Gunturu, Krishna S., Xiaopan Yao, Xiangyu Cong, et al.. (2012). FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity. Medical Oncology. 30(1). 361–361. 115 indexed citations
19.
Gunturu, Krishna S., Priyadharsini Nagarajan, Peter McPhedran, et al.. (2011). Ayurvedic herbal medicine and lead poisoning. Journal of Hematology & Oncology. 4(1). 51–51. 44 indexed citations
20.
Gunturu, Krishna S., Kenneth R. Meehan, Todd A. MacKenzie, et al.. (2010). Cytokine Working Group Study of Lymphodepleting Chemotherapy, Interleukin-2, and Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Metastatic Melanoma: Clinical Outcomes and Peripheral-Blood Cell Recovery. Journal of Clinical Oncology. 28(7). 1196–1202. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Vadiaka Breakdown of academic impact, for papers by Angélique Da Silva Breakdown of academic impact, for papers by Demetris Papamichael Breakdown of academic impact, for papers by Mehmet Küçüköner Breakdown of academic impact, for papers by Michael Cecchini Breakdown of academic impact, for papers by Yingyi Zhang Breakdown of academic impact, for papers by Tomohiro Sakamoto Breakdown of academic impact, for papers by Oktay Bozkurt Breakdown of academic impact, for papers by Anne‐Flore Plane Breakdown of academic impact, for papers by Xiaojuan Zhang
Rankless by CCL
2026